These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Pseudomonas keratitis after laser in situ keratomileusis. Sharma N; Sinha R; Singhvi A; Tandon R J Cataract Refract Surg; 2006 Mar; 32(3):519-21. PubMed ID: 16631068 [TBL] [Abstract][Full Text] [Related]
31. Comparison of besifloxacin, gatifloxacin, and moxifloxacin against strains of pseudomonas aeruginosa with different quinolone susceptibility patterns in a rabbit model of keratitis. Sanders ME; Moore QC; Norcross EW; Sanfilippo CM; Hesje CK; Shafiee A; Marquart ME Cornea; 2011 Jan; 30(1):83-90. PubMed ID: 20847656 [TBL] [Abstract][Full Text] [Related]
32. Bacterial keratitis early after corneal crosslinking with riboflavin and ultraviolet-A. Pollhammer M; Cursiefen C J Cataract Refract Surg; 2009 Mar; 35(3):588-9. PubMed ID: 19251154 [TBL] [Abstract][Full Text] [Related]
33. Fluoroquinolones or fortified antibiotics for treating bacterial keratitis: systematic review and meta-analysis of comparative studies. Hanet MS; Jamart J; Chaves AP Can J Ophthalmol; 2012 Dec; 47(6):493-9. PubMed ID: 23217502 [TBL] [Abstract][Full Text] [Related]
34. Clinical response of contact lens-associated fungal keratitis to topical fluoroquinolone therapy. Munir WM; Rosenfeld SI; Udell I; Miller D; Karp CL; Alfonso EC Cornea; 2007 Jun; 26(5):621-4. PubMed ID: 17525664 [TBL] [Abstract][Full Text] [Related]
35. Fluoroquinolone therapy in a rabbit model of post-LASIK methicillin-resistant Staphylococcus aureus keratitis. Balzli CL; McCormick CC; Caballero AR; Huang B; Wigington L; Smith E; Tang A; O'Callaghan RJ J Cataract Refract Surg; 2008 Feb; 34(2):295-301. PubMed ID: 18242457 [TBL] [Abstract][Full Text] [Related]
36. Fourth-generation fluoroquinolone-resistant mycobacterial keratitis after laser in situ keratomileusis. Moshirfar M; Meyer JJ; Espandar L J Cataract Refract Surg; 2007 Nov; 33(11):1978-81. PubMed ID: 17964409 [TBL] [Abstract][Full Text] [Related]
37. Fluoroquinolone treatment and susceptibility of isolates from bacterial keratitis. Ray KJ; Prajna L; Srinivasan M; Geetha M; Karpagam R; Glidden D; Oldenburg CE; Sun CQ; McLeod SD; Acharya NR; Lietman TM JAMA Ophthalmol; 2013 Mar; 131(3):310-3. PubMed ID: 23307105 [TBL] [Abstract][Full Text] [Related]
38. Secondary bacterial keratitis associated with shield ulcer caused by vernal conjunctivitis. Gedik S; Akova YA; Gür S Cornea; 2006 Sep; 25(8):974-6. PubMed ID: 17102679 [TBL] [Abstract][Full Text] [Related]
39. Effect of the fourth-generation fluoroquinolones on corneal reepithelialization after penetrating keratoplasty. Sahu SK; Murthy SI; Sangwan VS; Thomas R Cornea; 2006 Oct; 25(9):1130; author reply 1130-1. PubMed ID: 17133074 [No Abstract] [Full Text] [Related]
40. The steroids for corneal ulcers trial (SCUT): secondary 12-month clinical outcomes of a randomized controlled trial. Srinivasan M; Mascarenhas J; Rajaraman R; Ravindran M; Lalitha P; O'Brien KS; Glidden DV; Ray KJ; Oldenburg CE; Zegans ME; Whitcher JP; McLeod SD; Porco TC; Lietman TM; Acharya NR; Am J Ophthalmol; 2014 Feb; 157(2):327-333.e3. PubMed ID: 24315294 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]